Clinical Trial for Ovarian Cancer (OvaRex®)

PHASE3TerminatedINTERVENTIONAL
Enrollment

354

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

December 31, 2007

Conditions
Ovarian Cancer
Interventions
DRUG

oregovomab

Trial Locations (62)

10011

St. Vincent's Comprehensive Cancer Center, New York

10960

Nyack Hospital, Nyack

11030

North Shore University Hospital, Manhasset

13210

SUNY-HSC Syracuse, Crouse Hospital, Syracuse

22908

University of Virginia Cancer Center, Charlottesville

23502

VA Oncology Associates, Norfolk

24014

Carilion GYN Oncology Associates, Roanoke

27710

Duke University Medical Center, Durham

28203

Blumenthal Cancer Center, Charlotte

29203

South Carolina Oncology Associates, Columbia

29601

Gynecologic Oncology Research and Development, Greenville

30912

Medical College of Georgia, Augusta

32504

Pensacola Research Consultants, Pensacola

32804

Florida Hospital Cancer Institute, Orlando

33901

Florida Gynecologic Oncology, Fort Myers

35801

Comprehensive Cancer Institute, Huntsville

37403

Chattanooga GYN Oncology, Chattanooga

38120

West Clinic, PC, Memphis

39202

Women's Specialty Center, Jackson

40202

Brown Cancer Center, Louisville

Louisville Oncology, Louisville

43222

GYN Oncology and Pelvic Surgery Associates, Columbus

43606

ProMedica Health Systems, Toledo

44106

University Hospital - Health Systems, Cleveland

46260

St. Vincent Gynecologic Oncology, Indianapolis

46617

Michiana Hematology Oncology PC, South Bend

60637

The University of Chicago Hospitals, Chicago

65203

Ellis Fischel Cancer Center, Columbia

70115

Hematology and Oncology Specialists, New Orleans

70601

Lake Charles Medical Surgical Clinic, Lake Charles

72205

Little Rock Hematology Oncology Assoc., Little Rock

73104

Oklahoma University Health Sciences Center, Oklahoma City

76012

Arlington Cancer Center, Arlington

76104

Texas Oncology, Fort Worth

The Center for Cancer and Blood Disorders, Fort Worth

78705

Southwest Regional Cancer Center, Austin

80218

Rocky Mountain Cancer Center-Midtown, Denver

84106

Utah Cancer Specialists, Salt Lake City

85006

Western Regional Community Clinical Oncology Program, Phoenix

90048

Cedars-Sinai Medical Center, Los Angeles

91750

Wilshire Oncology Medical Group, La Verne

92123

Sharp Memorial Hospital, San Diego

92663

Gynecologic Oncology Associates, Newport Beach

92835

St. Jude Medical Center, Fullerton

92868

University of California, Irvine, Orange

94305

Stanford University, Stanford

97210

Northwest Cancer Specialists-Northrup, Portland

98104

Swedish Medical Center, Seattle

98684

Northwest Cancer Specialists-Vancouver, Vancouver

99218

Cancer Care Northwest, Spokane

90095-1740

UCLA School of Medicine, Los Angeles

06030

University of Connecticut Cancer Center, Farmington

06790

Northwestern Connecticut Oncology Hematology Associates, LLP, Torrington

33612-9497

H. Lee Moffitt Cancer Center and Research, Tampa

21237-3998

The Harry and Jeanette Weinberg Cancer Institute, Baltimore

02111

New England Medical Center, Boston

07754

Jersey Shore Medical Center, Neptune City

43614-5809

Medical College of Ohio Cancer Institute, Toledo

15213-3180

Magee-Womens Hospital, Pittsburgh

02905

Brown University School of Medicine, Providence

75235-9032

Univ. of Texas SW Medical Center at Dallas, Dallas

75246-2006

Texas Oncology, PA, Dallas

Sponsors
All Listed Sponsors
lead

Unither Pharmaceuticals

INDUSTRY